S1 kills MCF-7/ADR cells more than MCF-7 cells: A protective mechanism of endoplasmic reticulum stress

Ting Song1, Furong Liang, Zhichao Zhang

  • 1State Key Laboratory of Fine Chemicals, School of Chemistry, Dalian University of Technology, Dalian, China.

Insights

Pan-BH3 mimetic S1 effectively targets drug-resistant breast cancer cells. Defective endoplasmic reticulum (ER) stress in these cells enhances their sensitivity to S1-induced apoptosis.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Death Mechanisms

Background:

  • Chemotherapy resistance in breast cancer is linked to P-glycoprotein (P-gp) and endoplasmic reticulum (ER) stress.
  • Understanding resistance mechanisms is crucial for developing effective breast cancer therapies.

Purpose of the Study:

  • To evaluate the efficacy of the pan-BH3 mimetic S1 on drug-resistant MCF-7/ADR breast cancer cells.
  • To investigate the role of S1-induced ER stress in mediating cell death in these resistant cells.

Main Methods:

  • Treatment of MCF-7 and MCF-7/ADR cells with pan-BH3 mimetic S1.
  • Assessment of mitochondrial apoptosis via Bax/Bak activation and cytochrome c release.
  • Analysis of ER stress response pathways (IRE1, JNK, ERK) and Bcl-2 phosphorylation using coimmunoprecipitation and western blotting.
  • Evaluation of synergistic effects with ERK inhibitor PD98059.

Main Results:

  • S1 induced faster and greater mitochondrial apoptosis in drug-resistant MCF-7/ADR cells compared to MCF-7 cells.
  • P-glycoprotein had minimal impact on S1's cellular entry and target engagement.
  • S1 triggered an IRE1-mediated ER stress response and JNK/ERK activation in sensitive MCF-7 cells, but not in resistant MCF-7/ADR cells.
  • ER stress protected against S1-induced apoptosis by promoting Bcl-2 phosphorylation, sequestering pro-apoptotic proteins.
  • Defective ER stress in MCF-7/ADR cells correlated with increased sensitivity to S1.

Conclusions:

  • Pan-BH3 mimetic S1 demonstrates significant efficacy against P-gp-mediated drug-resistant breast cancer cells.
  • ER stress plays a protective role in S1-induced apoptosis, and its absence in resistant cells enhances sensitivity.
  • Targeting ER stress pathways may offer novel therapeutic strategies for overcoming chemotherapy resistance in breast cancer.

Related Concept Videos

Role of ER in the Secretory Pathway01:17

Role of ER in the Secretory Pathway

Eukaryotic cells have a special pathway that enables communication between various intracellular membrane-bound compartments and also with the extracellular environment. This pathway is termed as the secretory pathway.
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...